Notably, ASOs-synthetic nucleic acid sequences engineered to bind to specific chemerin mRNA, leading to its degradation and blocking its translation, can be analyzed as a potential therapeutic strategy for controlling hypertension, particularly in obesity-related cases. This evidence concerns the gene RARRES2 and hypertensive disorder.